New News information at World Pharmaceutical Frontiers New and updated information from News listed on www.worldpharmaceuticals.net http://www.worldpharmaceuticals.net/ en-us http://www.worldpharmaceuticals.net/ New News information at World Pharmaceutical Frontiers http://www.worldpharmaceuticals.net/content/images/logo_big.gif LogiPharma Unveils 2024 Agenda Featuring Big Pharma Players http://www.worldpharmaceuticals.net/news/newslogipharma-unveils-2024-agenda-featuring-big-pharma-players-11647299 http://www.worldpharmaceuticals.net/news/newslogipharma-unveils-2024-agenda-featuring-big-pharma-players-11647299 by <br/> <br/> LogiPharma, the world's largest life sciences supply chain event has unveiled its highly anticipated 2024 agenda, spotlighting key themes and speakers for this year's show, which takes place in Lyon, France, 16th – 18th April. Mon, 01 Apr 2024 06:34:00 GMT Chemspec Europe 2024: Connect with the world of fine and speciality chemicals http://www.worldpharmaceuticals.net/news/newschemspec-europe-2024-connect-with-the-world-of-fine-and-speciality-chemicals-11603805 http://www.worldpharmaceuticals.net/news/newschemspec-europe-2024-connect-with-the-world-of-fine-and-speciality-chemicals-11603805 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/11603805/thumbnail.jpg'/></a>The Ticket Shop is now open for Chemspec Europe 2024 – The key marketplace for fine and speciality chemicals, bespoke solutions, services, and equipment. Fri, 15 Mar 2024 05:31:00 GMT Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System http://www.worldpharmaceuticals.net/news/newsgenezen-enters-licensing-agreement-with-csl-for-the-cytegrity-stable-lentivirus-production-system-11540954 http://www.worldpharmaceuticals.net/news/newsgenezen-enters-licensing-agreement-with-csl-for-the-cytegrity-stable-lentivirus-production-system-11540954 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/11540954/thumbnail.jpg'/></a>Licensing of a proven stable producer system for lentiviral vector production represents a significant investment in next-generation technology for Genezen, offering its clients immediate access to cutting edge technology for stable and scalable high-titer clinical lentivirus production. Thu, 22 Feb 2024 12:09:00 GMT Faubel Becomes CCL Faubel http://www.worldpharmaceuticals.net/news/newsfaubel-becomes-ccl-faubel-11505448 http://www.worldpharmaceuticals.net/news/newsfaubel-becomes-ccl-faubel-11505448 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/11505448/thumbnail.jpg'/></a>The Faubel Group now operates under a new name following its takeover by CCL Industries Inc. Fri, 09 Feb 2024 11:37:00 GMT Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC http://www.worldpharmaceuticals.net/news/newsalloy-therapeutics-and-wheeler-bio-announce-preferred-service-offering-for-alloy-partners-to-accelerate-the-translation-from-discovery-to-cmc-091123-11286254 http://www.worldpharmaceuticals.net/news/newsalloy-therapeutics-and-wheeler-bio-announce-preferred-service-offering-for-alloy-partners-to-accelerate-the-translation-from-discovery-to-cmc-091123-11286254 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/11286254/thumbnail.jpg'/></a>Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced today the formation of a non-exclusive, preferred service offering to drive translation from Discovery to CMC development and clinical material supply for ecosystem partners. The organizations are collaborating to provide a premiere service experience for Alloy partners requiring CMC development services from Wheeler as a high-quality, reliable CMC service provider for development and GMP manufacturing. Thu, 09 Nov 2023 12:38:00 GMT SAVE THE DATE for Chemspec Europe 2024 Where Fine and Speciality Chemicals Meet Innovation http://www.worldpharmaceuticals.net/news/newssave-the-date-for-chemspec-europe-2024-where-fine-and-speciality-chemicals-meet-innovation-11227743 http://www.worldpharmaceuticals.net/news/newssave-the-date-for-chemspec-europe-2024-where-fine-and-speciality-chemicals-meet-innovation-11227743 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/11227743/thumbnail.jpg'/></a>Chemspec Europe 2024 is confirmed to take place from 19 - 20 June 2024, with Messe Düsseldorf, Germany, as its next stop to showcase the full array of fine and speciality chemicals, bespoke solutions, services, and equipment. Following the success of the 2023 edition, which featured 353 exhibitors from 24 countries on a record net exhibition space of 6,672.5 m2, stand requests for next year are already in high demand. With stand booking now open to all new exhibitor enquiries, 8 months before the show, 80% of floor space has already been allocated. Wed, 18 Oct 2023 05:31:00 GMT Wheeler Bio Announces Grand Opening of Biomanufacturing Facility http://www.worldpharmaceuticals.net/news/newswheeler-bio-announces-grand-opening-of-biomanufacturing-facility-11199665 http://www.worldpharmaceuticals.net/news/newswheeler-bio-announces-grand-opening-of-biomanufacturing-facility-11199665 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/11199665/thumbnail.jpg'/></a>Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, announced today the grand opening of their state-of-the-art drug substance Current Good Manufacturing Practices (CGMP) facility inside the Ziggurat building (Echo Investment Capital) in Oklahoma City, OK. Fri, 06 Oct 2023 10:09:00 GMT Chemspec Europe 2023: Record exhibition space and immense visitor growth propel the event to pre-pandemic levels and beyond http://www.worldpharmaceuticals.net/news/newschemspec-europe-2023-record-exhibition-space-and-immense-visitor-growth-propel-the-event-to-pre-pandemic-levels-and-beyond-10910820 http://www.worldpharmaceuticals.net/news/newschemspec-europe-2023-record-exhibition-space-and-immense-visitor-growth-propel-the-event-to-pre-pandemic-levels-and-beyond-10910820 by <br/> <br/> The 36th International Exhibition for Fine and Speciality Chemicals concluded last week at the Messe Basel exhibition centre in Switzerland. The largest edition of Chemspec Europe in size so far, the event welcomed 353 exhibitors from 24 countries, presenting their innovative substances and bespoke solutions on a record net exhibition space of 6,672.5 m2. Increasing visitor numbers by 32% compared to last year’s edition, the show attracted a total of 4,152 trade visitors from 62 countries. With visitor attendance matching the 2019 results, Chemspec Europe again confirmed its position in the sector by hitting pre-pandemic levels on event size and attendee numbers. Fri, 02 Jun 2023 13:10:00 GMT Chemspec Europe 2023: a record-breaking edition reconfirms the importance of the event for the international fine and speciality chemicals industry http://www.worldpharmaceuticals.net/news/newschemspec-europe-2023-a-record-breaking-edition-reconfirms-the-importance-of-the-event-for-the-international-fine-and-speciality-chemicals-industry-10862974 http://www.worldpharmaceuticals.net/news/newschemspec-europe-2023-a-record-breaking-edition-reconfirms-the-importance-of-the-event-for-the-international-fine-and-speciality-chemicals-industry-10862974 by <br/> <br/> Next week, from 24 - 25 May, Chemspec Europe 2023 will open its doors at Messe Basel, Switzerland, to offer a unique marketplace for product sourcing, whilst connecting industry experts worldwide and providing valuable updates on trends and regulations via an extensive conference programme. With a highly specialised exhibition profile, the 36th International Exhibition for Fine and Speciality Chemicals is the meeting point for buyers, traders, and agents searching for bespoke, new approaches and innovative substances. Thu, 18 May 2023 12:43:00 GMT Genezen announces presentation at 2023 Annual Meeting of the American Society of Gene and Cell Therapy http://www.worldpharmaceuticals.net/news/newsgenezen-announces-presentation-at-2023-annual-meeting-of-the-american-society-of-gene-and-cell-therapy-10811002-10811002 http://www.worldpharmaceuticals.net/news/newsgenezen-announces-presentation-at-2023-annual-meeting-of-the-american-society-of-gene-and-cell-therapy-10811002-10811002 by <br/> <br/> Genezen, a leading gene and cell therapy contract development and manufacturing organization (CDMO) announced a poster presentation at the 26th Annual American Society for Gene and Cell Therapy (ASGCT) Conference in Los Angeles in May – highlighting the results of its evaluation of novel technologies for lentiviral physical titer determination. Tue, 02 May 2023 23:00:00 GMT